Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.
Edd SN, Castañeda J, Choudhary P, Kolassa R, Keuthage W, Kroeger J, Thivolet C, Evans M, Ré R, Cellot J, de Portu S, Vorrink L, Shin J, van den Heuvel T, Cohen O; ADAPT study Group. Edd SN, et al. Among authors: cohen o. Diabetes Obes Metab. 2023 Nov;25(11):3212-3222. doi: 10.1111/dom.15217. Epub 2023 Aug 8. Diabetes Obes Metab. 2023. PMID: 37551542 Clinical Trial.
OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R, Cohen O, Conget I, Runzis S, Castaneda J, de Portu S, Lee S, Reznik Y; OpT2mise Study Group. Aronson R, et al. Among authors: cohen o. Diabetes Technol Ther. 2014 Jul;16(7):414-20. doi: 10.1089/dia.2013.0363. Epub 2014 Apr 15. Diabetes Technol Ther. 2014. PMID: 24735134 Clinical Trial.
The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
Conget I, Castaneda J, Petrovski G, Guerci B, Racault AS, Reznik Y, Cohen O, Runzis S, de Portu S, Aronson R; OpT2mise Study Group. Conget I, et al. Among authors: cohen o. Diabetes Technol Ther. 2016 Jan;18(1):22-8. doi: 10.1089/dia.2015.0159. Epub 2015 Aug 4. Diabetes Technol Ther. 2016. PMID: 26241790 Free PMC article. Clinical Trial.
Response to Letter to the Editor Regarding OpT2mise Study.
Conget I, Aronson R, Cohen O, Reznik Y. Conget I, et al. Among authors: cohen o. Diabetes Technol Ther. 2016 Jul;18(7):448. doi: 10.1089/dia.2016.0081. Epub 2016 Apr 4. Diabetes Technol Ther. 2016. PMID: 27043892 No abstract available.
1,108 results